Parexel International (MA) Corp.
Company Snapshot
Founded: 1982
Entity Type: Private
Region: U.S.
Headquarter: North Carolina, U.S.
Key Geographics: North America, Latin America, Europe, Asia-Pacific, Middle East and Africa
Corporate Address: 541 Church at North Hills Street, Suite 1000, Raleigh, North Carolina 27609, U.S. Tel. +1-919-544-3170 www.parexel.com
Company Overview
Parexel International (MA) Corp., a global biopharmaceutical services provider, offers comprehensive end-to-end clinical development solutions, including regulatory strategy, Phase I-IV trials and market access, to clients worldwide. Its segments include integrated clinical development, patient engagement, real-world evidence and supply chain logistics, with decentralized clinical trials (DCTs) integrated into clinical development for hybrid models that include home visits and telehealth. The clinical development segment assists with protocol design and site strategies to improve patient access. Its DCT capabilities align with its focus on risk-based trial execution.
Parexel International (MA) Corp. In News
Company's Business Segments
- Clinical Research Organizations (CROs) and Biopharmaceutical Services : The company provides a wide range of outsourcing services, including clinical trials, consulting, and medical communications.
Applications/End User Industries
- Biopharmaceutical
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Life Sciences